Antibody Development Deal

AnaptysBio Has Commenced an Antibody Development Program with Momenta Pharmaceuticals
Dec 20, 2013
US-based privately-held therapeutic antibody firm AnaptysBio has commenced an antibody development program with Momenta Pharmaceuticals, focused on the development of new antibodies against a therapeutically relevant target. Both the ...

Tags: Anaptysbio, Antibody Development Deal